Get started
Author

Jose Lázaro Pérez Calle

Observed names: J L Perez Calle, J L Pérez Calle, J.L. Pérez Calle, Jose L. Perez Calle, Jose L. Pérez Calle, Jose Lázaro Perez Calle, José L Pérez Calle, José L. Pérez Calle, José Lázaro Pérez Calle
ORCID: 0000-0002-8724-2760
Observed ORCID: 0000-0002-8724-2760
OpenAlex ID: A5081494149
Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
2018 · María Chaparro, Ana Garre, et al. · Alimentary Pharmacology & Therapeutics · 107
PDF
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
2019 · Ivan Guerra, Luis Bujanda, et al. · Journal of Crohn s and Colitis · 54
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
2022 · María Chaparro, Diana Acosta, et al. · The American Journal of Gastroenterology · 36
Predictors of response to infliximab in patients with fistulizing Crohn's disease
2004 · M. Luna-Chadid, J.L. Pérez Calle, et al. · Revista Española de Enfermedades Digestivas · 28
PDF
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
2024 · Carla J. Gargallo-Puyuelo, Elena Ricart, et al. · Clinical Gastroenterology and Hepatology · 24
PDF
Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry
2020 · Margalida Calafat, Míriam Mañosa, et al. · Journal of Crohn s and Colitis · 11
Enfermedades inflamatorias mediadas por inmunidad en pacientes con enfermedad inflamatoria intestinal. Datos basales del estudio Aquiles
2014 · Ignacio Marín-Jiménez, Valle García Sánchez, et al. · Gastroenterología y Hepatología · 10
Absceso hepático y enfermedad de Crohn. Presentación de 3 casos
2004 · J. Molina Infante, R. Bañares Cañizares, et al. · Gastroenterología y Hepatología · 8
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence
2024 · Antonio Giordano, Isabel Pérez-Martínez, et al. · The American Journal of Gastroenterology · 7
Psychological disorders and coping strategies in patients with Inflammatory Bowel Disease. Their impact in health-related quality of life.
2023 · Lorena Jara Fernández, Juan Ángel Ferrer, et al. · Revista Española de Enfermedades Digestivas · 6
Submaxilitis aguda secundaria a la toma de azatioprina en paciente con enfermedad de Crohn
2017 · Adriana Guerra Romero, José Lázaro Pérez Calle, et al. · Gastroenterología y Hepatología · 5
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
2022 · Yamile Zabana, Ignacio Marín-Jiménez, et al. · Journal of Clinical Medicine · 4
PDF
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study
2021 · Carlos Taxonera, María Pilar Martínez-Montiel, et al. · Therapeutic Advances in Gastroenterology · 3
Estudio del VOT en pacientes intervenidos de fisura palatina
2006 · R. Fernández-Valadés, J L Pérez Calle, et al. · 3
Macrocreatincinasa tipo 1 en pacientes diagnosticados de colitis ulcerosa
2001 · I.M. Marcos, C. Trascasa, et al. · Gastroenterología y Hepatología · 3
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
2024 · Iván Guerra, Francisco Barros, et al. · Digestive Diseases · 1
P675 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases
2023 · M Chaparro, D Acosta, et al. · Journal of Crohn s and Colitis · 1
Is cervical dysplasia a major concern in women with inflammatory bowel disease?. A spanish retrospective study
2023 · Lorena Jara Fernández, Juan Ángel Ferrer, et al. · Revista Española de Enfermedades Digestivas · 1
Evolution of a patient with submaxillitis secondary to azathioprine, 4 years later
2022 · Adriana R. Guerra Romero, Pilar López Serrano, et al. · Gastroenterología y Hepatología (English Edition) · 1
P373 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, impact of extraintestinal manifestations and immunomediated diseases and safety
2022 · M Chaparro, D Acosta, et al. · Journal of Crohn s and Colitis · 1
Does Biological Therapy Protect against Severe COVID-19?
2020 · Ramon Mazzucchelli, Raquel Almodovar González, et al. · medRxiv · 1
PDF
Azathioprine-induced acute submandibular sialadenitis in a patient with Crohn's disease
2018 · Adriana Guerra Romero, José Lázaro Pérez Calle, et al. · Gastroenterología y Hepatología (English Edition) · 1
P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry
2018 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
P666 Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry
2018 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
P275 Clinical characteristics, associated malignancies and management of primary sclerosing colangitis in inflammatory bowel disease patients: A Spanish nationwide study based on the ENEIDA registry
2018 · I Guerra, L Bujanda, et al. · Journal of Crohn s and Colitis · 1
Works count: 37
Citation count: 320
H-index: 8
I10-index: 7
Year
Topic
Type